| Thomas Eagan, DO, | |
|
1075 Sw Grandview Avenue, Ste. 200, Grants Pass, OR 97527 | |
| (541) 479-8363 | |
| (541) 476-2841 |
| Full Name | Thomas Eagan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 1075 Sw Grandview Avenue, Grants Pass, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578713673 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DO156868 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Asante Three Rivers Medical Center | Grants pass, OR | Hospital |
| Asante Ashland Community Hospital | Ashland, OR | Hospital |
| Asante Rogue Regional Medical Center | Medford, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Women's Health Center Of Southern Oregon Pc | 8628041720 | 15 |
News Archive
The Centre for Genomic Regulation in Barcelona has today launched Europe's first continent-wide PhD training programme for medical doctors.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).
Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).
Stents can be placed in the brain to treat a stroke as it's occurring, suggests preliminary data being presented at the 21st Annual International Symposium on Endovascular Therapy (ISET).
› Verified 9 days ago
| Entity Name | Women's Health Center Of Southern Oregon Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528175437 PECOS PAC ID: 8628041720 Enrollment ID: O20040817000751 |
News Archive
The Centre for Genomic Regulation in Barcelona has today launched Europe's first continent-wide PhD training programme for medical doctors.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).
Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).
Stents can be placed in the brain to treat a stroke as it's occurring, suggests preliminary data being presented at the 21st Annual International Symposium on Endovascular Therapy (ISET).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Eagan, DO, 1075 Sw Grandview Avenue, Ste. 200, Grants Pass, OR 97527 Ph: (541) 479-8363 | Thomas Eagan, DO, 1075 Sw Grandview Avenue, Ste. 200, Grants Pass, OR 97527 Ph: (541) 479-8363 |
News Archive
The Centre for Genomic Regulation in Barcelona has today launched Europe's first continent-wide PhD training programme for medical doctors.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced its intention to complete the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, for all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc., upon its currently scheduled expiration at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010).
Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).
Stents can be placed in the brain to treat a stroke as it's occurring, suggests preliminary data being presented at the 21st Annual International Symposium on Endovascular Therapy (ISET).
› Verified 9 days ago
Dr. Raymond Gambrill, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1075 Sw Grandview Ave, Ste 200, Grants Pass, OR 97527 Phone: 541-479-8363 Fax: 541-476-2841 | |
Dr. Tamara C. Medley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1075 Sw Grandview Avenue, Ste 200, Grants Pass, OR 97527 Phone: 541-479-8363 Fax: 541-476-2841 | |
Dr. Felicia Cohen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1075 Sw Grandview Avenue, Ste 200, Grants Pass, OR 97527 Phone: 541-479-8363 Fax: 541-476-2841 | |
Caroline Lansing Kelly, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1075 Grandview Ave Ste 200, Grants Pass, OR 97527 Phone: 541-479-8363 Fax: 541-476-2841 |